Compound Detail
CHEMBL259571
TAPINAROF 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL259571 |
| Name | TAPINAROF |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | ZISJNXNHJRQYJO-CMDGGOBGSA-N |
| Therapeutic | ✓ Yes |
2
Targets
4
Activities
2
Assay Types
0
PK Parameters
17
Publications
6
Known Names
2
Indications
1
Mechanisms
Molecular Properties
254.3
MW (Da)
4.39
ALogP
2
HBA
2
HBD
40.5
PSA (Ų)
0.80
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2022 |
| Availability | Prescription |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Aryl hydrocarbon receptor agonist | AGONIST | Aryl hydrocarbon receptor | ✓ | ✓ |
Indications
Psoriasis Dermatitis, Atopic
ATC Classification
D05AX07
tapinarof
Level 1: DERMATOLOGICALS
Level 2: ANTIPSORIATICS
Activity Summary
EC50 3 meas. best 7.89
IC50 1 meas. best 5.28
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Aryl hydrocarbon receptor CHEMBL3201 | EC50 | 7.89 | 7.6733 | 13.0 | 3 |
| CD4+ve Th CHEMBL613544 | IC50 | 5.28 | 5.28 | 5200.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Aryl hydrocarbon receptor | EC50 | = | 13.0 | nM | 7.89 | Agonist activity at human AhR by TR-FRET assay | 39137454 |
| Aryl hydrocarbon receptor | EC50 | = | 27.0 | nM | 7.57 | Agonist activity at AHR in human HepG2-Lucia AhR cells stably transfected with D... | 37348572 |
| Aryl hydrocarbon receptor | EC50 | = | 27.34 | nM | 7.56 | Agonist activity at AhR in human recombinant HepG2-Lucia AhR cell incubated for ... | 35123295 |
| CD4+ve Th | IC50 | = | 5200.0 | nM | 5.28 | Induction of apoptosis in human CD4+ve Th cells | 35123295 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 17284598 | 10.1073/pnas.0610525104 | Photorhabdus luminescens | 6 |
| 18407564 | 10.1002/ps.1591 | Caenorhabditis elegans | 2 |
| 37348572 | 10.1016/j.bmcl.2023.129383 | Aryl hydrocarbon receptor | 2 |
| 35123295 | 10.1016/j.ejmech.2022.114122 | Aryl hydrocarbon receptor | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 1 |
| 39137454 | 10.1016/j.ejmech.2024.116759 | Aryl hydrocarbon receptor | 1 |
| 37348572 | 10.1016/j.bmcl.2023.129383 | Mus musculus | 1 |
| - | 10.6019/EOS300108 | HepG2 | 1 |
| 35123295 | 10.1016/j.ejmech.2022.114122 | CD4+ve Th | 1 |
| 36459434 | 10.1021/acs.jmedchem.2c00956 | Unchecked | 1 |
| 17284598 | 10.1073/pnas.0610525104 | Prophenoloxidase | 1 |
| 25988621 | 10.1021/np500974f | Escherichia coli | 1 |
| 25988621 | 10.1021/np500974f | Saccharomyces cerevisiae | 1 |
| 25988621 | 10.1021/np500974f | Bacillus subtilis | 1 |
| 17284598 | 10.1073/pnas.0610525104 | Hemolymph | 1 |
| 17284598 | 10.1073/pnas.0610525104 | Manduca sexta | 1 |
Data from ChEMBL 36 via Core Engine